Close Menu

This article has been updated with comments from Roche's earnings call.

NEW YORK – Roche today reported flat half-year revenues for its Diagnostics division. At constant exchange rates, diagnostics revenues were up 2 percent, primarily due to the immunodiagnostics business as well as to overall growth in the second quarter.

For the first half of 2019, the Roche Group reported CHF 30.47 billion ($30.86 billion) in total sales, up 8 percent (9 percent at constant exchange rates) from CHF 28.11 billion during the first half of 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.